Metabolic memory in diabetes - focus on insulin

被引:71
作者
LeRoith, D
Fonseca, V
Vinik, A
机构
[1] Georgetown Univ, Sch Med, Washington, DC 20057 USA
[2] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA
[3] Eastern Virginia Med Sch, Diabet Res Inst, Norfolk, VA 23501 USA
关键词
insulin; metabolic memory; diabetes; microvascular complications; macrovascular complications; anti-inflammatory;
D O I
10.1002/dmrr.530
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Large-scale clinical trials have demonstrated that metabolic control achieved early in the course of diabetes substantially reduces development and progression of diabetes and the associated microvascular complications. Additionally, prospective observational studies have demonstrated that atherogenic and inflammatory mediators are elevated even prior to the onset of diabetes and significantly contribute to subsequent development of macrovascular complications. Collectively, these data suggest that metabolic memories are stored early in the course of diabetes. We believe that insulin suppresses inflammation and also suppresses glucotoxicity and lipotoxicity (and the consequences thereof, such as the formation of advanced glycation end products and epigenetic phenomena), and thus has a pivotal and beneficial role. Comprehensive metabolic control, especially when instituted early, may alter the natural history of diabetic complications by affecting this metabolic memory. Thus, our overall goal is to understand in more detail the molecular mechanisms involved in these changes, thereby affording us opportunities to reduce the long-term effects of diabetes. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:85 / 90
页数:6
相关论文
共 43 条
[1]  
[Anonymous], 1995, Diabetes, V44, P1249
[2]   Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells [J].
Artwohl, M ;
Roden, M ;
Waldhäusl, W ;
Freudenthaler, A ;
Baumgartner-Parzer, SM .
FASEB JOURNAL, 2004, 18 (01) :146-148
[3]  
BROWNLEE M, 1990, DIABETES MELLITUS TH, P279
[4]   ADVANCED GLYCOSYLATION PRODUCTS QUENCH NITRIC-OXIDE AND MEDIATE DEFECTIVE ENDOTHELIUM-DEPENDENT VASODILATATION IN EXPERIMENTAL DIABETES [J].
BUCALA, R ;
TRACEY, KJ ;
CERAMI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :432-438
[5]   15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].
CANNER, PL ;
BERGE, KG ;
WENGER, NK ;
STAMLER, J ;
FRIEDMAN, L ;
PRINEAS, RJ ;
FRIEDEWALD, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255
[6]  
CLEARY P, 2003, AM DIAB ASS 63 AN S1, V52, pA152
[7]   Protein carbonylation in human diseases [J].
Dalle-Donne, I ;
Giustarini, D ;
Colombo, R ;
Rossi, R ;
Milzani, A .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (04) :169-176
[8]   The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm [J].
Dandona, P ;
Aljada, A ;
Mohanty, P .
DIABETOLOGIA, 2002, 45 (06) :924-930
[9]   PROGRESSION OF INCIPIENT DIABETIC-RETINOPATHY DURING GOOD GLYCEMIC CONTROL [J].
ENGERMAN, RL ;
KERN, TS .
DIABETES, 1987, 36 (07) :808-812
[10]   Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
CIRCULATION, 2000, 102 (01) :42-47